Tiago L Duarte, Marta Lopes, Mónica Oliveira, Ana G Santos, Catarina Vasco, Joana P Reis, Ana Rita Antunes, Andreia Gonçalves, Sérgio Chacim, Cláudia Oliveira, Beatriz Porto, Maria José Teles, Ana C Moreira, André M N Silva, Ron Schwessinger, Hal Drakesmith, Rui Henrique, Graça Porto, Delfim Duarte
Iron overload (IOL) is hypothesized to contribute to dysplastic erythropoiesis. Several conditions, including myelodysplastic syndrome, thalassemia and sickle cell anemia, are characterized by ineffective erythropoiesis and IOL. Iron is pro-oxidant and may participate in the pathophysiology of these conditions by increasing genomic instability and altering the microenvironment. There is, however, lack of in vivo evidence demonstrating a role of IOL and oxidative damage in dysplastic erythropoiesis. NRF2 transcription factor is the master regulator of antioxidant defenses, playing a crucial role in the cellular response to IOL in the liver...
October 19, 2023: Leukemia